Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials

By sjmartinez • July 1, 2024

Korman NJ, Warren RB, Bagel J, Armstrong AW, Gooderham M, Strober B, Thaçi D, Morita A, Imafuku S, Foley P, Sofen H, Zheng M, Hippeli L, Kisa RM, Banerjee S, Blauvelt A. Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials. J Dermatolog Treat. 2024 Dec;35(1):2371045. doi: 10.1080/09546634.2024.2371045. Epub 2024 Jun 30. PMID: 38945549.

Tags: clinical trials, Dermatology, deucravacitinib, maintenance of response, onset of action, phase 3, POETYK PSO-1, POETYK PSO-2, psoriasis, Publications

Techniques and analytic workflow for spatial transcriptomics and its application to allergy and inflammation

Zhang H, Patrick MT, Zhao J, Zhai X, Liu J, Li Z, Gu Y, Welch J, Zhou X, Modlin R, Tsoi LC, Gudjonsson JE. Techniques[...]

Peterson H, Miao KL, Huang MY, Armstrong AW. Trending Psychiatric Comorbidities in Patients with Alopecia Areata in the United States from 2002 to 2019. J[...]

Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment

Gorelick J, Nguyen A, Schneider SKR, Martel BC, Madsen DE, Armstrong AW. Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the[...]